170
Participants
Start Date
August 10, 2016
Primary Completion Date
March 9, 2022
Study Completion Date
March 9, 2022
Nivolumab
Specified dose on specified days, IV (intravenous)
Elotuzumab
Specified dose on specified days, IV
Pomalidomide
Specified dose on specified days, PO (by mouth)
Dexamethasone
Specified dose on specified days, PO
Local Institution - 0026, Vienna
Wilhelminenspital, Vienna
Hopitaux Universitaires de Geneve, Geneva
Local Institution - 0075, Stavanger
Local Institution - 0029, Linz
Klinikum Wels-Grieskirchen Gmbh, Wels
Local Institution, Odense
Universitaetsklinik Salzburg, Salzburg
Local Institution, Aarhus
Mount Sinai Medical Center, New York
Local Institution - 0017, New York
Local Institution - 0042, Turin
Alexandra General Hospital Of Athens, Athens
Local Institution - 0050, Berlin
Broome Oncology LLC, Johnson City
Local Institution - 0064, Huddinge
Local Institution - 0010, Buffalo
Local Institution - 0136, Lancaster
Local Institution - 0036, Sayre
Local Institution - 0021, Philadelphia
Local Institution - 0147, Washington D.C.
Local Institution - 0018, Bethesda
Local Institution - 0006, Baltimore
Emily Couric Clinical Cancer Center, Charlottesville
Virginia Cancer Institute, Richmond
Local Institution - 0135, Kiel
Local Institution - 0089, Bergamo
Local Institution - 0096, Winston-Salem
Local Institution - 0001, Durham
Local Institution - 0101, Pozuelo de Alarcón
Local Institution - 0152, Greenville
Local Institution - 0009, Atlanta
Local Institution - 0024, Atlanta
Local Institution - 0119, Athens
Augusta University, Augusta
Local Institution - 0097, Pamplona
Cancer Specialists of North FL, Jacksonville
Local Institution - 0130, Tallahassee
Local Institution - 0082, Pensacola
Local Institution - 0114, Hollywood
Local Institution - 0125, West Palm Beach
Local Institution - 0011, Boynton Beach
Local Institution - 0126, St. Petersburg
Florida Cancer Specialists S., Fort Myers
Local Institution - 0186, Istanbul
Local Institution - 0160, Mobile
Local Institution - 0099, Salamanca
Tennessee Oncology, PLLC - SCRI - PPDS, Nashville
Local Institution - 0069, Germantown
Local Institution - 0137, Hattiesburg
A. O. U. Di Bologna, Policlinico S. Orsola Malpighi, Bologna
Uniklinikum Duesseldorf, Düsseldorf
Local Institution - 0012, Columbus
Indiana University Cancer Ctr, Indianapolis
Local Institution - 0111, Fort Wayne
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola (FC)
Local Institution - 0150, Ypsilanti
Local Institution, Ramat Gan
Klinikum Der Johannes Gutenberg Universitaet Mainz, Mainz
Azienda Ospedaliero Universitaria Ospedali Riuniti Di Ancona, Ancona
Local Institution - 0035, Chicago
St. Louis Cancer Care, Llp, Bridgeton
Washington University, St Louis
Local Institution - 0128, Kansas City
Local Institution, Tel Aviv
Local Institution - 0049, Springfield
Local Institution - 0079, Lincoln
Local Institution - 0163, Fayetteville
University Of Oklahoma, Oklahoma City
Baylor Research Institute, Dallas
Local Institution - 0044, Houston
Local Institution - 0037, San Antonio
Colorado Blood Cancer Institute, Denver
Poudre Valley Health Care, Fort Collins
Local Institution - 0116, Grand Junction
Local Institution - 0087, Beersheba
Local Institution - 0153, Salt Lake City
Local Institution - 0022, Ogden
Local Institution - 0054, Ulm
Local Institution - 0138, Los Angeles
Local Institution - 0155, Los Angeles
Local Institution - 0117, Redondo Beach
Local Institution - 0164, La Jolla
Local Institution - 0092, Riverside
Local Institution - 0016, Fountain Valley
Local Institution - 0093, Corona
Local Institution - 0118, Bakersfield
Coastal Integrative Cancer Care, San Luis Obispo
Local Institution - 0113, Santa Maria
Local Institution - 0145, Portland
Local Institution - 0144, Seattle
Local Institution, Petah Tikva
Local Institution, Jerusalem
Local Institution - 0020, Birmingham
UC San Diego Moores Cancer Ctr, La Jolla
Yale University School Of Medicine, New Haven
Local Institution - 0123, Worcester
Local Institution - 0076, Flemington
Local Institution - 0002, Hackensack
Local Institution - 0095, New Brunswick
Local Institution - 0142, Paramus
Local Institution - 0046, Temple
Local Institution, Edmonton
Local Institution, Vancouver
Local Institution - 0074, Toronto
Local Institution - 0039, Montreal
MUHC - Glen Site, Montreal
Local Institution - 0154, Montreal
Local Institution, Québec
Local Institution - 0157, Rimouski
Interni hematologicka a onkologicka klinika, Brno
Klinika hematoonkologie, Ostrava-Poruba
I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze, Prague
Universitaetsklinikum Carl Gustav Carus, Dresden
Azienda Ospedaliera Santa Maria Terni, Terni
Local Institution, Oslo
Local Institution - 0132, Lisbon
Local Institution, Porto
Local Institution - 0071, San Juan
Local Institution - 0098, Badalona-Barcelona
Local Institution - 0100, Barcelona
Lead Sponsor
Collaborators (1)
AbbVie
INDUSTRY
Bristol-Myers Squibb
INDUSTRY